Research portfolio management in Beacon, New York

Welcome to Beacon Pointe Advisors, your trusted partner in financial planning and investment advisory services, located at 2488 Montauk Highway, Bridgehampton, New York. As one of the nation's largest Registered Investment Advisor firms, we are dedicated to serving the New York area with a comprehensive range of services, including investment advisory, financial planning, wealth management, and retirement plan services. At Beacon Pointe Advisors, we pride ourselves on our fiduciary responsibility to our clients, ensuring that your financial well-being is at the forefront of everything we do. Our holistic allWEALTH® approach covers all aspects of financial planning, from wealth and retirement strategies to estate and tax planning, insurance reviews, and risk assessments. We also specialize in values-based investing, life transition support, and multi-generational wealth and legacy planning.

Paul Ellis Consulting is a reputable finance institution located at 35 Washington Avenue in Beacon, New York, United States. With a team of experienced financial experts, they offer a wide range of consulting services to help individuals and businesses achieve their financial goals. Whether you need assistance with investment planning, budgeting, or financial analysis, Paul Ellis Consulting is dedicated to providing personalized solutions tailored to your specific needs. Trust in their expertise and commitment to excellence for all your financial consulting needs.

Welcome to the Comprehensive Cancer Center at Montefiore Einstein, located at 600 East 233rd Street, The Bronx, New York 10466. As part of the premier Montefiore Einstein academic health system, we are dedicated to pushing the boundaries of medical science and patient care. Our center is a beacon of hope and healing, offering cutting-edge treatments and compassionate care for individuals battling cancer. Montefiore Einstein is renowned for its groundbreaking research and life-saving discoveries, supported by substantial National Institutes of Health (NIH) funding. Our commitment to innovation is reflected in our robust portfolio of over 850 active clinical trials, translating scientific breakthroughs into effective diagnostics and treatments.